Global Folic Acid Injection Market Research Report 2024

Publication ID:

PB502245096

Publication Date:

March 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Folic Acid Injection is a sterile, nonpyrogenic solution of sodium folate prepared by the addition of sodium hydroxide to folic acid in Water for Injection intended for intramuscular, intravenous or subcutaneous use. Folic acid is a B-complex vitamin needed to form healthy cells, especially red blood cells. Folic acid is used to treat or prevent certain anemias caused by poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, or other conditions.
The global Folic Acid Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Folic Acid Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Folic Acid Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Folic Acid Injection include Merck & Co, Eli Lilly, Sandoz Canada Incorporated, Ceva Animal Health Australia, Shanghai Pharmaceuticals and Anhui Medipharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Folic Acid Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Folic Acid Injection.
Report Scope
The Folic Acid Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Folic Acid Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Folic Acid Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Shanghai Pharmaceuticals
Anhui Medipharm
Segment by Type
Folic Acid Inj 5mg/ml
Folic Acid Inj 30mg/2ml
Segment by Application
Elderly
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Folic Acid Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Folic Acid Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Folic Acid Injection Market Overview
1.1 Product Overview and Scope of Folic Acid Injection
1.2 Folic Acid Injection Segment by Type
1.2.1 Global Folic Acid Injection Market Value Comparison by Type (2024-2030)
1.2.2 Folic Acid Inj 5mg/ml
1.2.3 Folic Acid Inj 30mg/2ml
1.3 Folic Acid Injection Segment by Application
1.3.1 Global Folic Acid Injection Market Value by Application: (2024-2030)
1.3.2 Elderly
1.3.3 Children
1.3.4 Adult
1.4 Global Folic Acid Injection Market Size Estimates and Forecasts
1.4.1 Global Folic Acid Injection Revenue 2019-2030
1.4.2 Global Folic Acid Injection Sales 2019-2030
1.4.3 Global Folic Acid Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Folic Acid Injection Market Competition by Manufacturers
2.1 Global Folic Acid Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Folic Acid Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Folic Acid Injection Average Price by Manufacturers (2019-2024)
2.4 Global Folic Acid Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Folic Acid Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Folic Acid Injection, Product Type & Application
2.7 Folic Acid Injection Market Competitive Situation and Trends
2.7.1 Folic Acid Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Folic Acid Injection Players Market Share by Revenue
2.7.3 Global Folic Acid Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Folic Acid Injection Retrospective Market Scenario by Region
3.1 Global Folic Acid Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Folic Acid Injection Global Folic Acid Injection Sales by Region: 2019-2030
3.2.1 Global Folic Acid Injection Sales by Region: 2019-2024
3.2.2 Global Folic Acid Injection Sales by Region: 2025-2030
3.3 Global Folic Acid Injection Global Folic Acid Injection Revenue by Region: 2019-2030
3.3.1 Global Folic Acid Injection Revenue by Region: 2019-2024
3.3.2 Global Folic Acid Injection Revenue by Region: 2025-2030
3.4 North America Folic Acid Injection Market Facts & Figures by Country
3.4.1 North America Folic Acid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Folic Acid Injection Sales by Country (2019-2030)
3.4.3 North America Folic Acid Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Folic Acid Injection Market Facts & Figures by Country
3.5.1 Europe Folic Acid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Folic Acid Injection Sales by Country (2019-2030)
3.5.3 Europe Folic Acid Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Folic Acid Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Folic Acid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Folic Acid Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Folic Acid Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Folic Acid Injection Market Facts & Figures by Country
3.7.1 Latin America Folic Acid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Folic Acid Injection Sales by Country (2019-2030)
3.7.3 Latin America Folic Acid Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Folic Acid Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Folic Acid Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Folic Acid Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Folic Acid Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Folic Acid Injection Sales by Type (2019-2030)
4.1.1 Global Folic Acid Injection Sales by Type (2019-2024)
4.1.2 Global Folic Acid Injection Sales by Type (2025-2030)
4.1.3 Global Folic Acid Injection Sales Market Share by Type (2019-2030)
4.2 Global Folic Acid Injection Revenue by Type (2019-2030)
4.2.1 Global Folic Acid Injection Revenue by Type (2019-2024)
4.2.2 Global Folic Acid Injection Revenue by Type (2025-2030)
4.2.3 Global Folic Acid Injection Revenue Market Share by Type (2019-2030)
4.3 Global Folic Acid Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Folic Acid Injection Sales by Application (2019-2030)
5.1.1 Global Folic Acid Injection Sales by Application (2019-2024)
5.1.2 Global Folic Acid Injection Sales by Application (2025-2030)
5.1.3 Global Folic Acid Injection Sales Market Share by Application (2019-2030)
5.2 Global Folic Acid Injection Revenue by Application (2019-2030)
5.2.1 Global Folic Acid Injection Revenue by Application (2019-2024)
5.2.2 Global Folic Acid Injection Revenue by Application (2025-2030)
5.2.3 Global Folic Acid Injection Revenue Market Share by Application (2019-2030)
5.3 Global Folic Acid Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co
6.1.1 Merck & Co Corporation Information
6.1.2 Merck & Co Description and Business Overview
6.1.3 Merck & Co Folic Acid Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co Folic Acid Injection Product Portfolio
6.1.5 Merck & Co Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Folic Acid Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Folic Acid Injection Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sandoz Canada Incorporated
6.3.1 Sandoz Canada Incorporated Corporation Information
6.3.2 Sandoz Canada Incorporated Description and Business Overview
6.3.3 Sandoz Canada Incorporated Folic Acid Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Canada Incorporated Folic Acid Injection Product Portfolio
6.3.5 Sandoz Canada Incorporated Recent Developments/Updates
6.4 Ceva Animal Health Australia
6.4.1 Ceva Animal Health Australia Corporation Information
6.4.2 Ceva Animal Health Australia Description and Business Overview
6.4.3 Ceva Animal Health Australia Folic Acid Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Animal Health Australia Folic Acid Injection Product Portfolio
6.4.5 Ceva Animal Health Australia Recent Developments/Updates
6.5 Shanghai Pharmaceuticals
6.5.1 Shanghai Pharmaceuticals Corporation Information
6.5.2 Shanghai Pharmaceuticals Description and Business Overview
6.5.3 Shanghai Pharmaceuticals Folic Acid Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Pharmaceuticals Folic Acid Injection Product Portfolio
6.5.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.6 Anhui Medipharm
6.6.1 Anhui Medipharm Corporation Information
6.6.2 Anhui Medipharm Description and Business Overview
6.6.3 Anhui Medipharm Folic Acid Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anhui Medipharm Folic Acid Injection Product Portfolio
6.6.5 Anhui Medipharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Folic Acid Injection Industry Chain Analysis
7.2 Folic Acid Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Folic Acid Injection Production Mode & Process
7.4 Folic Acid Injection Sales and Marketing
7.4.1 Folic Acid Injection Sales Channels
7.4.2 Folic Acid Injection Distributors
7.5 Folic Acid Injection Customers
8 Folic Acid Injection Market Dynamics
8.1 Folic Acid Injection Industry Trends
8.2 Folic Acid Injection Market Drivers
8.3 Folic Acid Injection Market Challenges
8.4 Folic Acid Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Shanghai Pharmaceuticals
Anhui Medipharm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂